Etanercept plus sulfasalazine: added value in rheumatoid arthritis?

Etanercept plus sulfasalazine: added value in rheumatoid arthritis?

Opis bibliograficzny
Główni autorzy:	Fisher, B, Taylor, P
Format:	Journal article
Język:	English
Wydane:	2007

Podobne zapisy

Sulfasalazine plus Chloroquine-Induced Mood Disorder in a Patient with Rheumatoid Arthritis
od: Gulcan Gulec, i wsp.
Wydane: (2009-03-01)

Etanercept for the treatment of rheumatoid arthritis.
od: Blumenauer, B, i wsp.
Wydane: (2003)

Etanercept for the treatment of rheumatoid arthritis
od: Blumenauer, B, i wsp.
Wydane: (2004)

Etanercept for the treatment of rheumatoid arthritis.
od: Lethaby, A, i wsp.
Wydane: (2013)

Quality of life of patients with rheumatoid arthritis receiving etanercept
od: V N Amirdzanova, i wsp.
Wydane: (2009-08-01)

Etanercept In the treatment of AA-amyloidosis in juvenile rheumatoid arthritis
od: H Mihels
Wydane: (2004-08-01)

The role of etanercept in the treatment of patients with severe rheumatoid arthritis
od: N. V. Chichasova
Wydane: (2013-12-01)

Comparative Effects of Combination Therapies; Methotrexate with Leflunomide & Sulfasalazine in the Treatment of Rheumatoid Arthritis
od: Qurrat-ul-Ain Bukhari, i wsp.
Wydane: (2017-06-01)

Etanercept in the treatment of Graves’ ophthalmopathy with primary hypothyroidism and rheumatoid arthritis
od: Olivera Boskovic, i wsp.
Wydane: (2020-01-01)

Effectiveness of dose reduction of etanercept and adalimumab in patients with rheumatoid arthritis
od: Martínez-Pérez Rosalía, i wsp.
Wydane: (2011-11-01)

Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
od: Jian Cao, i wsp.
Wydane: (2019-05-01)

Ultrasonographic assessment of the response to Etanercept treatment in patients with rheumatoid arthritis
od: G. Valesini, i wsp.
Wydane: (2011-09-01)

Efficacy and safety of the biosimilar etanercept in the treatment of patients with rheumatoid arthritis and spondyloarthritis
od: B. G. Issayeva, i wsp.
Wydane: (2024-10-01)

Decrease in articular hypoxia and synovial blood flow at early time points following infliximab and etanercept treatment in rheumatoid arthritis
od: Fisher, B, i wsp.
Wydane: (2016)

EFFICACY OF ETANERCEPT IN CHILD WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
od: T.M. Bzarova, i wsp.
Wydane: (2011-03-01)

EFFICACY OF ETANERCEPT IN CHILD WITH SEVERE POLYARTICULAR TYPE OF JUVENILE RHEUMATOID ARTHRITIS
od: T.M. Bzarova, i wsp.
Wydane: (2011-01-01)

Etanercept-Induced Pityriasis Lichenoides Chronica in a Patient with Rheumatoid Arthritis
od: Andrés F. Echeverri, i wsp.
Wydane: (2015-01-01)

Predictors of Response to (Etanercept) in the Treatment of Iraqi Patients with Active Rheumatoid Arthritis
od: Nizar A. Jassim
Wydane: (2015-04-01)

The effect of 677C>T and 1298A>C MTHFR polymorphisms on sulfasalazine treatment outcome in rheumatoid arthritis
od: A. Pawlik, i wsp.
Wydane: (2009-07-01)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: A systematic review and economic evaluation
od: Jobanputra, P, i wsp.
Wydane: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation.
od: Jobanputra, P, i wsp.
Wydane: (2002)

The effectiveness of infliximab and etanercept for the treatment of rheumatoid arthritis: a systematic review and economic evaluation
od: P. Jobanputra, i wsp.
Wydane: (2002-01-01)

Live macrophages loaded with Fe3O4 and sulfasalazine for ferroptosis and photothermal therapy of rheumatoid arthritis
od: Li Ruan, i wsp.
Wydane: (2024-02-01)

Why uncritical adherence to recommendations of sulfasalazine leaflet information can lead to medical error in rheumatoid arthritis?
od: Y V Muravyov
Wydane: (2003-04-01)

Influence of therapy with methotrexate, sulfasalazine and glucocorticoids on disease activity and erosions progression in patients with early rheumatoid arthritis
od: G Togizbaev, i wsp.
Wydane: (2007-10-01)

Case Report of Transverse Myelitis in a Patient Receiving Etanercept for Rheumatoid Arthritis
od: Helen Defty, i wsp.
Wydane: (2013-01-01)

Drug-induced cutaneous vasculitis developing during Etanercept treatment for rheumatoid arthritis
od: Maria N. Chamurlieva, i wsp.
Wydane: (2021-10-01)

Etanercept in Rheumatoid Arthritis: Long Term Anti-Inflammatory Efficacy in Clinical Practice
od: E. Cacace, i wsp.
Wydane: (2006-09-01)

Epidemiological and Clinical Factors Affecting the Response to Etanercept Among Patients with Rheumatoid Arthritis
od: Samer Imad Mohammed, i wsp.
Wydane: (2022-06-01)

Treatment with Etanercept in a Patient with Rheumatoid Arthritis-Associated Interstitial Lung Disease
od: Yu Wang, i wsp.
Wydane: (2011-01-01)

EFFICACY OF ETANERCEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS (results of the Russian multicenter ETALON study)
od: Anna Olegovna Pchelintseva, i wsp.
Wydane: (2014-02-01)

Comparison of efficacy and tolerability of triple combination therapy (methotrexate + sulfasalazine + hydroxychloroquine) with methotrexate monotherapy in patients with rheumatoid arthritis
od: E E Gubar', i wsp.
Wydane: (2008-05-01)

Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment
od: Shinya Hayashi, i wsp.
Wydane: (2022-10-01)

Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report
od: Tuite Helen, i wsp.
Wydane: (2010-11-01)

Clinical Outcomes in Iraqi Patients with Rheumatoid Arthritis Following Earlier or Later Treatment with Etanercept
od: Al-Ani N, i wsp.
Wydane: (2021-04-01)

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up.
od: E H Vogelzang, i wsp.
Wydane: (2018-01-01)

Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study
od: Nuria Carballo, i wsp.
Wydane: (2022-10-01)

Observational study of inflammatory arthritis treatment by etanercept originator switched to an etanercept biosimilar
od: Anna Felis-Giemza, i wsp.
Wydane: (2019-10-01)

The Association of Methotrexate, Sulfasalazine, and Hydroxychloroquine Use With Fracture in Postmenopausal Women With Rheumatoid Arthritis: Findings From the Women's Health Initiative
od: Laura Carbone, i wsp.
Wydane: (2020-10-01)

EFFICIENCY OF TRIPLE (METHOTREXATE + SULFASALAZINE + HYDROXYCHLOROQUINE) COMBINATION DISEASE-MODIFYING THERAPY VERSUS METOTREXATE MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS
od: E E Gubar', i wsp.
Wydane: (2011-04-01)